We are live on ! Find out more
BXRX

Baudax Bio, Inc. Common Stock
BXRX

Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

53 hedge funds and large institutions have $34.8M invested in Baudax Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Corsair Capital Management
New York
+$5.01M
2
BlackRock
BlackRock
New York
+$3.14M
3
ECM
Engine Capital Management
New York
+$2.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.31M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.77M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CEP
26
Chicago Equity Partners
Illinois
$188K +$162K +19 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$184K +$162K +19 New
CPP
28
Crow Point Partners
Massachusetts
$173K +$154K +18 New
Charles Schwab
29
Charles Schwab
California
$133K +$119K +14 New
Wells Fargo
30
Wells Fargo
California
$129K +$111K +13 New
MA
31
MYDA Advisors
New York
$121K +$111K +13 New
Morgan Stanley
32
Morgan Stanley
New York
$120K +$102K +12 New
CSS
33
Cubist Systematic Strategies
Connecticut
$112K +$102K +12 New
UBS Group
34
UBS Group
Switzerland
$92K +$85.3K +10 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$84K +$76.8K +9 New
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$79K +$68.3K +8 New
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$70K +$59.7K +7 New
CM
38
Caption Management
Oklahoma
$68K +$59.7K +7 New
DCM
39
Dupont Capital Management
Delaware
$59K +$51.2K +6 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$58K +$51.2K +6 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$42K +$34.1K +4 New
AIG
42
American International Group
New York
$34K +$25.6K +3 New
MAM
43
Meeder Asset Management
Ohio
$32K +$25.6K +3 New
Bank of America
44
Bank of America
North Carolina
$31K +$25.6K +3 New
SO
45
STRS Ohio
Ohio
$22K +$17.1K +2 New
JP Morgan Chase
46
JP Morgan Chase
New York
$19K +$17.1K +2 New
Deutsche Bank
47
Deutsche Bank
Germany
$18K +$17.1K +2 New
Victory Capital Management
48
Victory Capital Management
Texas
$15K +$17.1K +2 New
Russell Investments Group
49
Russell Investments Group
United Kingdom
$13K +$8.53K +1 New
Citigroup
50
Citigroup
New York
$11K +$8.53K +1 New
1
2
3

BXRX Hedge Fund Activity: Q4 2019 in Review

53 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Baudax Bio, Inc. Common Stock (BXRX) for Q4 2019, worth a combined $34.8M.

Buyers outnumbered sellers: 53 funds opened new BXRX positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Corsair Capital Management, opening a new position worth an estimated $5.01M.

  • 53 institutional investors held Baudax Bio, Inc. Common Stock (BXRX) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $34.8M of Baudax Bio, Inc. Common Stock stock for Q4 2019.
  • 53 funds opened new Baudax Bio, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +53 holders.
  • The largest Baudax Bio, Inc. Common Stock buyer in Q4 2019 was Corsair Capital Management, an estimated $5.01M added.

Based on aggregated 13F filings for Q4 2019.